Table 6.
Odds ratios (95% confidence intervals) | ||||
---|---|---|---|---|
Occurred/identified | Antecedent/correlate | Ante-/neonatal | Early postnatal | Late postnatal |
Antenatal/neonatal | Mother consumed aspirin | 2.1 (1.1, 4.1) | 2.1 (1.1, 4.2) | 2.1 (1.02, 4.2) |
Gestational age 23–24 wk | 2.8 (1.7, 4.8) | 1.9 (1.1, 3.6) | 1.4 (0.8, 2.6) | |
Gestational age 25–26 wk | 1.8 (1.1, 2.9) | 1.5 (0.9, 2.4) | 1.3 (0.8, 2.1) | |
Birth weight Z score <–2 | 2.2 (1.1, 4.2) | 2.0 (1.00, 2.7) | 1.6 (0.8, 3.2) | |
Early postnatal | SNAP-II ≥30 | 1.8 (1.2, 2.7) | 1.6 (1.00, 2.4) | |
Postnatal steroidb | 1.7 (1.1, 2.6) | 1.4 (0.9, 2.2) | ||
Definite late bacteremiac | 1.6 (1.1, 2.3) | 1.4 (0.9, 2.1) | ||
Late postnatal | Ventriculomegaly | 2.3 (1.3, 3.9) | ||
Type I ROP | 2.5 (1.5, 4.0) | |||
BPD ventilator-dependentd | 2.8 (1.6, 4.8) |
Abbreviations: BPD, bronchopulmonary dysplasia; ROP, retinopathy of prematurity; SNAP-II, Score for Neonatal Acute Physiology.
These are calculated from time-oriented logistic risk models. Variables were retained in the model if the P value when they first entered the model was <.01. Bold items are statistically significant.
Hydrocortisone or dexamethasone.
Culture proven bacteremia in weeks 2–4.
On ventilator as well as oxygen at 36 weeks postmenstrual age.